Jeani Delagardelle

Vasca, Inc. develops access and related technologies. It manufactures and markets life site hemodialysis access system technologies to improve the quality of patient care in the United States. The company was founded by Jeffrey H. Burbank in April 1996 and is headquartered in Tewksbury, MA.

Lightspeed Management Co. LLC (Lightspeed Venture Partners) is a venture capital firm founded in 1971. The firm is headquartered in Menlo Park, California. It was formerly known as Weiss, Peck & Greer Venture Partners.

World Heart Corp. develops artificial heart and related technologies. The company was founded on April 1, 1996 and is headquartered in Salt Lake City, UT.

Direct Flow Medical, Inc. develops transcatheter heart valve technologies. It explores application of its technology beyond the aortic valve, to the mitral valve, and other valve anatomy. The firm’s Transcatheter Aortic Valve System is indicated for the treatment of patients with severe aortic stenosis, who are at risk for surgical aortic valve replacement. The company's system incorporates a polymer frame, which is expanded using pressurized saline and contrast for placement, assessment and repositioning. Direct Flow Medical was founded by Gordon B. Bishop and Randall T. Lashinski in June 2004 and is headquartered in Santa Rosa, CA.

Part of Roche Holding AG, Roche Laboratories, Inc. markets and sells pharmaceutical medications. The company is based in Nutley, NJ.

Part of CMIC Holdings Co., Ltd., Cell Product, Inc. is a Japanese company that provides services in Site Management Organization (SMO). The company is based in Sapporo, Japan. Cell Product was acquired by SSI-CP Co., Ltd. on January 05, 2006.

Gryphon Therapeutics, Inc. develops and produces protein therapeutics. Its products combine chemically synthesized protein backbones with polyethylene glycols, such as molecules to create potent medications. Gryphon Therapeutics was founded in 1993 and is headquartered in South San Francisco, CA

ReShape Medical, Inc. develops non-surgical medical devices for the treatment of obesity. The company is headquartered in San Mateo, CA.

Spiracur, Inc. develops innovative wound healing technologies. Its products include smart negative pressure wound care system that includes cartridge, hydrocolloid dressing, and interface layer for the treatment of chronic and acute wounds; and ciSNaP closed incision systems, including sterile cartridges, controlled tension relief layers, advanced surgical dressing, and straps for patients undergoing high-risk procedures, including orthopedic, abdominal, vascular, and podiatric surgeries. The company was founded by Kenton D. Fong and Moshe Pinto in 2007 and is headquartered in Sunnyvale, CA.

CardioKinetix, Inc. develops ventricular partitioning device for heart failure disease. It develops transcatheter implant called the Parachute Ventricular Partitioning Device, which intends to treat heart failure resulting from a heart attack in patients by improving overall cardiac function. The company was founded by Alexander Khairkhahan, Serjan D. Nikolic and Hugh R. Sharkey in 2002 and is headquartered in Menlo Park, CA.

Altura Medical, Inc. manufactures medical devices. It offers Agili-D AAA System, an endovascular aneurysm repair technology. The company was founded in 2008 and is headquartered in Irvine, CA.

Delos Advisors Ltd (Delos Capital) is a private equity and venture capital firm founded by Lin Zheng Chen in 2014. The firm is headquartered in Hong Kong.

Epidarex Capital Partners LLC (Epidarex Capital) is a venture capital firm founded in 2010 by Kyparissia Sirinakisvin. The firm is headquartered in Bethesda, Maryland.